Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction

Circulation

Volumn 135, Issue 22, 2017, Pages 2106-2115

  Halliday, Brian P ^a,c,d   Gulati, Ankur ^a   Ali, Aamir ^a,c,d   Guha, Kaushik ^b,c,d   Newsome, Simon ^e   Arzanauskaite, Monika ^a   Vassiliou, Vassilios S ^a,c,d,f   Lota, Amrit ^a,c,d   Izgi, Cemil ^a   Tayal, Upasana ^a,c,d   Khalique, Zohya ^a   Stirrat, Colin ^g   Auger, Dominique ^a   Pareek, Nilesh ^b   Ismail, Tevfik F ^h   Rosen, Stuart D ^b,c,d,i   Vazir, Ali ^b,c,d   Alpendurada, Francisco ^a,c,d   Gregson, John ^e   Frenneaux, Michael P ^f   Cowie, Martin R ^b,c,d   Cleland, John G F ^a,c,d   Cook, Stuart A ^a,c,d,j   Pennell, Dudley J ^a,c,d   Prasad, Sanjay K ^a,c,d   more..

^a The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^b Department of Cardiology ^*  (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

ⁱ EALING HOSPITAL   (United Kingdom)

^j DEPARTMENT OF CARDIOLOGY   (Singapore)

more..

Author keywords

cardiovascular MRI; dilated cardiomyopathy; implantable cardioverter defibrillator; late gadolinium enhancement; sudden cardiac death

Indexed keywords

GADOLINIUM;

ADULT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SUDDEN CARDIAC DEATH; AGED; CARDIOMYOPATHY, DILATED; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADULT; AGED; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 85018833039     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.026910     Document Type: Review

References (35)

1. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW, ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. J Am Coll Cardiol 2013 61 1318 1368
2. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ, 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015 36 2793 2867
3. Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJ, Out-of-hospital cardiac arrest-the relevance of heart failure: the Maastricht Circulatory Arrest Registry. Eur Heart J 2003 24 1204 1209
4. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS, Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006 47 1161 1166. doi: 10.1016/j.jacc.2005.11.045.
5. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP, American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Heart Rhythm 2008 5 e1 e21
6. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen PS, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O'Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng ZJ, Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010 122 2335 2348. doi: 10.1161/CIRCULATIONAHA.110.976092.
7. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2006 114 e385 e484
8. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016 375 1221 1230. doi: 10.1056/NEJMoa1608029.
9. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O'Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013 309 896 908. doi: 10.1001/jama.2013.1363.
10. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ, Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006 48 1977 1985
11. Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA, Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012 5 448 456. doi: 10.1161/CIRCIMAGING.111.971549.
12. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ, Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012 60 408 420. doi: 10.1016/j.jacc.2012.02.070.
13. Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M, Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 2014 7 250 258. doi: 10.1161/CIRCIMAGING.113.001144.
14. Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H, Pribe R, Ehlermann P, Zugck C, Korosoglou G, Giannitsis E, Katus HA, Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011 97 727 732. doi: 10.1136/hrt.2010.205542.
15. Müller KA, Müller I, Kramer U, Kandolf R, Gawaz M, Bauer A, Zuern CS, Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study. PLoS One 2013 8 e57077. doi: 10.1371/journal.pone.0057077.
16. Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, Ghoshhajra BB, Kwong RY, CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. J Am Coll Cardiol. Cardiovasc Imaging 2013 6 944 954. doi: 10.1016/j.jcmg.2013.05.013.
17. Disertori M, Rigoni M, Pace N, Casolo G, Masè M, Gonzini L, Lucci D, Nollo G, Ravelli F, Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta- analysis. J Am Coll Cardiol. Cardiovasc Imaging 2016 9 1046 1055. doi: 10.1016/j.jcmg.2016.01.033.
18. Bilchick KC, The fault is in our scars: LGE and ventricular arrhythmia risk in LV dysfunction. J Am Coll Cardiol. Cardiovasc Imaging 2016 9 1056 1058. doi: 10.1016/j.jcmg.2015.12.025.
19. Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, Lafitte S, Al-Saadi N, Kuntz-Hehner S, Engelhardt M, Becher H, Vanoverschelde JL, Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 2005 26 607 616. doi: 10.1093/eurheartj/ehi083.
20. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T, Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004 44 1030 1035. doi: 10.1016/j.jacc.2004.05.068.
21. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016 18 891 975
22. Maceira AM, Prasad SK, Khan M, Pennell DJ, Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006 8 417 426
23. Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P, Cowie MR, Pennell DJ, Prasad SK, Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011 124 1351 1360. doi: 10.1161/CIRCULATIONAHA.110.011346.
24. Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL, 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials. Circulation 2015 132 302 361
25. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF, ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures. J Am Coll Cardiol 2006 48 2361 2378
26. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD, Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009 120 2069 2076. doi: 10.1161/CIRCULATIONAHA.109.852517.
27. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P, Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 2016 37 1850 1858. doi: 10.1093/eurheartj/ehv727.
28. Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H, Ebinger M, Pelosi F, Chugh A, Jongnarangsin K, Morady F, Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 2009 53 1138 1145. doi: 10.1016/j.jacc.2008.11.052.
29. de Bakker JM, Coronel R, Tasseron S, Wilde AA, Opthof T, Janse MJ, van Capelle FJ, Becker AE, Jambroes G, Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol 1990 15 1594 1607
30. Hsia HH, Marchlinski FE, Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev 2002 6 472 481
31. Estner HL, Zviman MM, Herzka D, Miller F, Castro V, Nazarian S, Ashikaga H, Dori Y, Berger RD, Calkins H, Lardo AC, Halperin HR, The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm 2011 8 1942 1949. doi: 10.1016/j.hrthm.2011.07.027.
32. Perez-David E, Arenal A, Rubio-Guivernau JL, del Castillo R, Atea L, Arbelo E, Caballero E, Celorrio V, Datino T, Gonzalez-Torrecilla E, Atienza F, Ledesma-Carbayo MJ, Bermejo J, Medina A, Fernández-Avilés F, Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol 2011 57 184 194. doi: 10.1016/j.jacc.2010.07.043.
33. Merlo M, Stolfo D, Anzini M, Negri F, Pinamonti B, Barbati G, Ramani F, Lenarda AD, Sinagra G, Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist? J Am Heart Assoc 2015 4 e001504. doi: 10.1161/JAHA.114.000570.
34. Chen Z, Sohal M, Voigt T, Sammut E, Tobon-Gomez C, Child N, Jackson T, Shetty A, Bostock J, Cooklin M, O'Neill M, Wright M, Murgatroyd F, Gill J, Carr-White G, Chiribiri A, Schaeffter T, Razavi R, Rinaldi CA, Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. Heart Rhythm 2015 12 792 801. doi: 10.1016/j.hrthm.2014.12.020.
35. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Hinojar R, Doltra A, Varma N, Child N, Rogers T, Suna G, Arroyo Ucar E, Goodman B, Khan S, Dabir D, Herrmann E, Zeiher AM, Nagel E, International T1 Multicentre CMR Outcome Study T1- mapping and outcome in nonischemic cardiomyopathy: all- cause mortality and heart failure. JACC Cardiovasc Imaging 2016 9 40 50. doi: 10.1016/j.jcmg.2015.12.001.